Timeline
PureTech's Seaport advances GlyphAgo into Phase 2 after positive Phase 1 multiple‑dose data
Seaport Therapeutics prices $254.9m Nasdaq IPO, London-listed PureTech gets a lift
Health & Bio Today: GSK's efimosfermin wins FDA Breakthrough and EMA PRIME status, PureTech Health, Ondine Biomedical, AstraZeneca
Seaport Therapeutics appoints Intra‑Cellular founder Sharon Mates to board
PureTech posts positive Phase 1b LYT-200 data and will prioritise relapsed/refractory high‑risk MDS
More in Telecoms
Vodafone Group shares soar after stake sale to Xavier Niel
French billionaire Xavier Niel is investing in Vodafone Group via his Vega entity, with funding provided entirely by Niel personally and financial institutions.